Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
2017; Oxford University Press; Volume: 38; Issue: 4 Linguagem: Inglês
10.1210/er.2017-00067
ISSN1945-7189
AutoresMegan R. Haymart, Nazanene H. Esfandiari, Michael T. Stang, J.A. Sosa,
Tópico(s)Radiation Dose and Imaging
ResumoControversy exists over optimal management of low-risk differentiated thyroid cancer. This controversy occurs in all aspects of management, including surgery, use of radioactive iodine for remnant ablation, thyroid hormone supplementation, and long-term surveillance. Limited and conflicting data, treatment paradigm shifts, and differences in physician perceptions contribute to the controversy. This lack of physician consensus results in wide variation in patient care, with some patients at risk for over- or undertreatment. To reduce patient harm and unnecessary worry, there is a need to design and implement studies to address current knowledge gaps.
Referência(s)